Surgical Research Service, Neurosciences Unit, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.
Prog Neurobiol. 2011 Mar;93(3):341-9. doi: 10.1016/j.pneurobio.2010.12.002. Epub 2010 Dec 14.
The aim of this paper is to identify current perspectives for cell therapy applied to traumatic injuries of the central nervous system (CNS). After using diverse types of cell therapy, at present there is a growing experimental evidence that transplantation of bone marrow stromal cells (BMSC) can be useful to reverse the sequels of trauma affecting the brain and spinal cord. Although we still do not know many details about how these cells achieve their beneficial effects, the application of BMSC in humans, for brain or spinal cord repair, is beginning. An exquisite caution and strict methodological controls are needed to determine with certainty whether we can open a door of hope for many patients who currently suffer severe neurological deficits that are now supposedly irreversible.
本文旨在探讨细胞治疗在中枢神经系统(CNS)创伤中的应用现状。目前,已有多种类型的细胞治疗方法被应用于临床,实验研究也证实骨髓基质细胞(BMSC)移植对脑和脊髓创伤后遗症具有一定的治疗作用。尽管我们还不完全清楚这些细胞发挥疗效的确切机制,但 BMSC 在脑和脊髓损伤修复中的临床应用已经开始。为了确定细胞治疗是否能为目前被认为无法治愈的严重神经功能缺损患者带来新的希望,我们需要进行更精细的临床研究和更严格的方法学控制。